Dexmedetomidine and Bupivacaine Intra-articular for Postoperative Analgesia After Knee Arthroscopic Surgery
Impact of Dexmedetomidine Add to Intra-articular Bupivacaine for Post Operative Analgesia After Knee Arthroscopic Surgery
Al-Azhar University
75 participants
Dec 1, 2024
INTERVENTIONAL
Conditions
Summary
The aim of this study to compare the analgesic effects of intraarticular dexmedetomidine added to bupivacaine with those of bupivacaine alone after knee arthroscopy
Eligibility
Inclusion Criteria4
- ASA I-II patients
- Either sex
- Aged 18-65 years
- Candidates for anterior cruciate ligament (ACL) reconstruction by knee arthroscopy
Exclusion Criteria3
- the patients with kidney failure, liver failure, valvular and ischemic heart disease , high blood pressure, diabetes, history of infection and malignancy.
- history of coagulation diseases, and history of drug allergies to used drugs.
- those who consumed NSAIDs and analgesics 24 h before surgery were excluded from the study.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
the 18 ml of normal saline will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure
the 18ml 0.25% bupivacaine. will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure
Dexmedetomidine 1 μg/kg will injected intra articular in the knee joint by the surgeon through the arthroscope after completing the procedure.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06665438